1. A Phase II Trial of Safety, Tolerability and Immunogenicity of V114, a 15-Valent Pneumococcal Conjugate Vaccine, Compared With 13-Valent Pneumococcal Conjugate Vaccine in Healthy Infants. Issue 8 (August 2020) Authors: Platt, Heather L.; Greenberg, David; Tapiero, Bruce; Clifford, Robert A.; Klein, Nicola P.; Hurley, David C.; Shekar, Tulin; Li, Jianing; Hurtado, Kim; Su, Shu-Chih; Nolan, Katrina M.; Acosta, Camilo J.; McFetridge, Richard D.; Bickham, Kara; Musey, Luwy K. Journal: Pediatric infectious disease journal Issue: Volume 39:Issue 8(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Safety and immunogenicity of 15-valent pneumococcal conjugate vaccine (PCV15) in healthy infants. Issue 45 (29th October 2018) Authors: Greenberg, David; Hoover, Patricia A.; Vesikari, Timo; Peltier, Christopher; Hurley, David C.; McFetridge, Richard D.; Dallas, Michael; Hartzel, Jonathan; Marchese, Rocio D.; Coller, Beth-Ann G.; Stek, Jon E.; Abeygunawardana, Chitrananda; Winters, Michael A.; MacNair, John E.; Pujar, Narahari S.... Journal: Vaccine Issue: Volume 36:Issue 45(2018) Page Start: 6883 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗